FR2306710B1 - - Google Patents

Info

Publication number
FR2306710B1
FR2306710B1 FR7610342A FR7610342A FR2306710B1 FR 2306710 B1 FR2306710 B1 FR 2306710B1 FR 7610342 A FR7610342 A FR 7610342A FR 7610342 A FR7610342 A FR 7610342A FR 2306710 B1 FR2306710 B1 FR 2306710B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7610342A
Other versions
FR2306710A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Publication of FR2306710A1 publication Critical patent/FR2306710A1/fr
Application granted granted Critical
Publication of FR2306710B1 publication Critical patent/FR2306710B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/78Polymers containing oxygen of acrylic acid or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
FR7610342A 1975-04-09 1976-04-08 Composition pour le traitement du colon Granted FR2306710A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7504049A SE7504049L (sv) 1975-04-09 1975-04-09 Colonpreparation

Publications (2)

Publication Number Publication Date
FR2306710A1 FR2306710A1 (fr) 1976-11-05
FR2306710B1 true FR2306710B1 (fr) 1979-07-13

Family

ID=20324216

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7610342A Granted FR2306710A1 (fr) 1975-04-09 1976-04-08 Composition pour le traitement du colon

Country Status (12)

Country Link
BE (1) BE840552A (fr)
DE (1) DE2614296A1 (fr)
DK (1) DK153376A (fr)
FI (1) FI56772C (fr)
FR (1) FR2306710A1 (fr)
GB (1) GB1538123A (fr)
IE (1) IE42793B1 (fr)
LU (1) LU74732A1 (fr)
NL (1) NL7603600A (fr)
NO (1) NO761101L (fr)
NZ (1) NZ180552A (fr)
SE (1) SE7504049L (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139715A (en) * 1976-05-14 1977-11-21 Nippon Kayaku Co Ltd Coated granules of alkali polyacrylate
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4444761A (en) * 1981-05-04 1984-04-24 Syntex (U.S.A.) Inc. Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4521401A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of quinidine
EP0273209B1 (fr) * 1986-12-30 1992-01-15 American Cyanamid Company Composition contenant un polycarbophile
GB8817015D0 (en) * 1988-07-16 1988-08-17 Reckitt & Colmann Prod Ltd Method of treatment
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
CA2082156A1 (fr) * 1990-05-04 1991-11-05 Amnon Sintov Systeme permettant l'administration d'un medicament dans le colon
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
DE9212938U1 (fr) * 1992-09-25 1992-11-26 Boehringer Ingelheim Gmbh, 6507 Ingelheim, De
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
WO2018191752A1 (fr) 2017-04-14 2018-10-18 Gelesis Llc Compositions et méthodes pour le traitement ou la prévention de troubles liés à la perméabilité intestinale

Also Published As

Publication number Publication date
GB1538123A (en) 1979-01-10
DE2614296A1 (de) 1976-10-21
FR2306710A1 (fr) 1976-11-05
NO761101L (fr) 1976-10-12
DK153376A (da) 1976-10-10
FI760948A (fr) 1976-10-10
FI56772B (fi) 1979-12-31
SE7504049L (sv) 1976-10-10
IE42793L (en) 1976-10-09
NZ180552A (en) 1978-07-28
IE42793B1 (en) 1980-10-22
FI56772C (fi) 1980-04-10
NL7603600A (nl) 1976-10-12
LU74732A1 (fr) 1977-02-04
BE840552A (fr) 1976-10-11

Similar Documents

Publication Publication Date Title
FI760948A (fr)
JPS5525307B2 (fr)
JPS51163382U (fr)
AU495933B2 (fr)
JPS5732447B2 (fr)
JPS5289740U (fr)
FI750387A (fr)
JPS51137666U (fr)
JPS5194426U (fr)
JPS5620120Y2 (fr)
JPS5436613Y2 (fr)
JPS5215188U (fr)
JPS5256313U (fr)
JPS5268614U (fr)
JPS5269176U (fr)
JPS5285261U (fr)
JPS5256233U (fr)
JPS5199064U (fr)
JPS51121232U (fr)
JPS51110065U (fr)
BG22450A1 (fr)
BG22500A1 (fr)
CH576760A5 (fr)
CH584777A5 (fr)
CH584904A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse